Revive Therapeutics Ltd (RVVTF)

$0.04 +0.00 (12.46%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 93,700
Avg Vol 669,160
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 46%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin, which i...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 888-901-0036
Fax: 905-248-3355
Address:
The Canadian Venture Building, 82 Richmond Street East, Toronto, Canada
Dirtymartini66
Dirtymartini66 Mar. 24 at 1:18 AM
$RVVTF Just breathe my fellow longs
0 · Reply
Tartufo
Tartufo Mar. 23 at 8:31 PM
$RVVTF today's a far cry from last week's volume, well at least we're up today. GLTA!
0 · Reply
LarryFeelTheHeaton
LarryFeelTheHeaton Mar. 23 at 2:38 PM
$RVVTF mm accumulation?
0 · Reply
Barron401k
Barron401k Mar. 23 at 2:35 PM
$RVVTF While human trials with live agents are illegal... CBRN response teams at Aberdeen 100% train with simulants like 2-chloroethyl phenyl sulfide (CEPS) or diethyl malonate to simulate mustard gas, vx, sarin, etc. You get a lungful of tear gas and conduct yourself without panic? you pass. So if animal/CAM trials went well, they 💯 would dose a unit up and send them to the test chamber to gauge human response. IF buccilamine protected CBRNers during the chamber test, it would be extremely obvious and extremely convincing. After such a performance, well, let's just say you would be hearing the word "procurement" a lot. 😉😎
0 · Reply
Bull80
Bull80 Mar. 23 at 2:13 PM
$RVVTF Neither bid nor ask is increasing, staying same for good amount of time.
0 · Reply
Canadianbull1324
Canadianbull1324 Mar. 23 at 1:47 PM
$RVVTF great day for news
1 · Reply
BobWarner99
BobWarner99 Mar. 23 at 12:53 AM
$RVVTF Trying looking for RVVTF. Nothing. If Policymakers, Government persons are possibly buying RVVTF then they might be using other means to buy.....that is if they are? Or maybe they may start buying possibly once Big News drops??? If possible, I sure wouldn't mind having some 0.77+ RVVTF shares in my post Easter Basket. Thanks in advance. 😁 https://www.capitoltrades.com/
1 · Reply
BobWarner99
BobWarner99 Mar. 23 at 12:28 AM
$RVVTF Could RVVTF's Molecular Hydrogen acquisition + Bucillamine 2.0 play a role for soldiers with dramatic brain injury?? 🤔 https://pmc.ncbi.nlm.nih.gov/articles/PMC9979207/
0 · Reply
SUPERKKING
SUPERKKING Mar. 23 at 12:03 AM
$RVVTF look at this from REEDIT … GOOGLE TREND from Washington and Providence … 👇 Wow guys… this huge volume is not a pump it’s accumulation … 😍
0 · Reply
Dirtymartini66
Dirtymartini66 Mar. 22 at 11:19 PM
$RVVTF Reddit (Logical-Concern9539) - HUGE! “”[0031] Results of the study indicate that bucillamine is a significantly more effective antioxidant than NAC and has increased efficacy against seizure activity while limiting the anticoagulant and bleeding event liability observed with NAC.” “The therapeutically effective amount of bucillamine can be administered as a pretreatment. The method or use wherein the pretreatment can be administered prior to the victim being exposed to the chemical agent.” This is huge! We’re not talking stockpile we’re talking soldiers taking it daily when in a battlezone. Think malaria prophylactics
0 · Reply
Latest News on RVVTF
No data available.
Dirtymartini66
Dirtymartini66 Mar. 24 at 1:18 AM
$RVVTF Just breathe my fellow longs
0 · Reply
Tartufo
Tartufo Mar. 23 at 8:31 PM
$RVVTF today's a far cry from last week's volume, well at least we're up today. GLTA!
0 · Reply
LarryFeelTheHeaton
LarryFeelTheHeaton Mar. 23 at 2:38 PM
$RVVTF mm accumulation?
0 · Reply
Barron401k
Barron401k Mar. 23 at 2:35 PM
$RVVTF While human trials with live agents are illegal... CBRN response teams at Aberdeen 100% train with simulants like 2-chloroethyl phenyl sulfide (CEPS) or diethyl malonate to simulate mustard gas, vx, sarin, etc. You get a lungful of tear gas and conduct yourself without panic? you pass. So if animal/CAM trials went well, they 💯 would dose a unit up and send them to the test chamber to gauge human response. IF buccilamine protected CBRNers during the chamber test, it would be extremely obvious and extremely convincing. After such a performance, well, let's just say you would be hearing the word "procurement" a lot. 😉😎
0 · Reply
Bull80
Bull80 Mar. 23 at 2:13 PM
$RVVTF Neither bid nor ask is increasing, staying same for good amount of time.
0 · Reply
Canadianbull1324
Canadianbull1324 Mar. 23 at 1:47 PM
$RVVTF great day for news
1 · Reply
BobWarner99
BobWarner99 Mar. 23 at 12:53 AM
$RVVTF Trying looking for RVVTF. Nothing. If Policymakers, Government persons are possibly buying RVVTF then they might be using other means to buy.....that is if they are? Or maybe they may start buying possibly once Big News drops??? If possible, I sure wouldn't mind having some 0.77+ RVVTF shares in my post Easter Basket. Thanks in advance. 😁 https://www.capitoltrades.com/
1 · Reply
BobWarner99
BobWarner99 Mar. 23 at 12:28 AM
$RVVTF Could RVVTF's Molecular Hydrogen acquisition + Bucillamine 2.0 play a role for soldiers with dramatic brain injury?? 🤔 https://pmc.ncbi.nlm.nih.gov/articles/PMC9979207/
0 · Reply
SUPERKKING
SUPERKKING Mar. 23 at 12:03 AM
$RVVTF look at this from REEDIT … GOOGLE TREND from Washington and Providence … 👇 Wow guys… this huge volume is not a pump it’s accumulation … 😍
0 · Reply
Dirtymartini66
Dirtymartini66 Mar. 22 at 11:19 PM
$RVVTF Reddit (Logical-Concern9539) - HUGE! “”[0031] Results of the study indicate that bucillamine is a significantly more effective antioxidant than NAC and has increased efficacy against seizure activity while limiting the anticoagulant and bleeding event liability observed with NAC.” “The therapeutically effective amount of bucillamine can be administered as a pretreatment. The method or use wherein the pretreatment can be administered prior to the victim being exposed to the chemical agent.” This is huge! We’re not talking stockpile we’re talking soldiers taking it daily when in a battlezone. Think malaria prophylactics
0 · Reply
Dirtymartini66
Dirtymartini66 Mar. 22 at 11:17 PM
$RVVTF highlighted on Reddit: (Diable24) The ongoing research into Bucillamine as a treatment for nerve agent exposure is highly promising. Its potent antioxidant properties and its ability to replenish glutathione through multiple mechanisms, including the activation of the Nrf2 pathway, position it as a strong candidate for mitigating the secondary neuronal damage that is a major contributor to the long- term morbidity of nerve agent poisoning.
0 · Reply
Dirtymartini66
Dirtymartini66 Mar. 22 at 10:58 PM
$RVVTF some of our reddit brethren are posting some amazing stuff - white paper and Israel being on the patent info - thanks for pointing it out @SUPERKKING
0 · Reply
SUPERKKING
SUPERKKING Mar. 22 at 6:26 PM
$RVVTF WOW 😍 International patent filling include Canada, USA and ISRAEL …. Something big coming ….
1 · Reply
SUPERKKING
SUPERKKING Mar. 22 at 11:33 AM
$RVVTF Take a good look at this; it could tell you a lot about what's coming. A Reddit user noticed a huge increase in searches for Revive Therapeutics in Ontario, where the DRDC and the majority of the Canadian government are located… 🤑
1 · Reply
sica1983
sica1983 Mar. 21 at 7:55 PM
$RVVTF and again, we are very early, just a few people..story is developing with strong evidence, stock is up 300% YTD..soon you will see people on Youtube covering the stock following the patents and government involvement, the will tell you is a good buy and can go to $1-$2, only thing by then the stock will be $0.20-0.30 and will have made most of the gains. Then the play will become very risky. So conclusion is we are in a very good spot.
0 · Reply
sica1983
sica1983 Mar. 21 at 6:41 PM
$RVVTF look at NVAX story, a dead 30+ year old company, they were waiting for the right catalyst , the stock was basically dead money. • Vaccine platform already built • Failed multiple times commercially • Stock: ~$3-$4 • Market cap: ~$200M Then NVAX had ALL of these at once: Global emergency • Government funding • Massive addressable market • Positive data momentum • Limited competition early • Retail + institutional hype A EXTREMELY rare combo. Stock went 75x to $300 Revive Therapeutics is a similar story just waiting for the right catalyst. DREAM BIG
2 · Reply
LarryFeelTheHeaton
LarryFeelTheHeaton Mar. 21 at 5:00 PM
$RVVTF Looks like I picked the wrong week to quit sniffing glue.
0 · Reply
sica1983
sica1983 Mar. 21 at 4:29 PM
$RVVTF I sent the following message to Revive Therapeutics contact page on their website and on Facebook page. Let’s see if they answer, Ill post here if they respond. I suggest you do the same. “Subject: Shareholder Inquiry – Nerve Agent Program Update Dear Revive Therapeutics Team, I am a long-term investor in Revive Therapeutics and remain very optimistic about the company’s direction, especially the nerve agent program. As a committed shareholder, I wanted to ask if you could provide any guidance or anticipated timing regarding the release of results from the nerve agent study. Your work is greatly appreciated, and I look forward to continued progress and updates. Best regards,”
0 · Reply
SUPERKKING
SUPERKKING Mar. 21 at 12:52 PM
$RVVTF BREAKING 👇 A study has already been conducted on rats and it is conclusive. 👇
1 · Reply
LarryFeelTheHeaton
LarryFeelTheHeaton Mar. 21 at 8:55 AM
$RVVTF rvvtf bagholders soon enough
0 · Reply
sica1983
sica1983 Mar. 21 at 4:56 AM
$RVVTF I am thinking even a BIG PHARMA involvement here ahead of announcement of the results, make so much sense because they acquires early to lock IP cheaply especially if mechanism is validated data is internally shared but not public. delayed results, nerve agent patent pending, infectious disease patent secured in Canada, multi-use asset hmm.. The drug is working and some arrangements are being made🤘
0 · Reply
sica1983
sica1983 Mar. 21 at 1:52 AM
$RVVTF too many things lining up..the results must be positive and the announcement should come up soon…this is serious stuff, we are in for some nice gains boys
0 · Reply